Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Compensation Expense
The following table presents a summary of the Company’s nonvested performance share units (“PSUs”) and restricted stock units (“RSUs”) for the three months ended March 31, 2023:
Awards Weighted Average Grant Date Fair Value
(in thousands)
Nonvested, at December 31, 2022
1,625  $ 8.82 
Granted 171  7.70 
Vested (219) 9.53 
Forfeited —  — 
Nonvested, at March 31, 2023
1,577  $ 8.60 
Schedule of Stock Option Activity
The following table presents a summary of the Company’s stock options activity for the three months ended March 31, 2023:
Number of Shares Weighted Average Exercise Price per Share Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands) (in years) (in thousands)
Options outstanding at December 31, 2022
684  $ 8.82 
Granted 228  6.46 
Exercised —  — 
Forfeited (184) 8.83 
Options outstanding at March 31, 2023
728  $ 8.08  9.27 $ — 
Options exercisable at March 31, 2023(1)
167  $ 8.82  8.96 $ — 
(1)    As of March 31, 2023, the exercisable stock options were out-of-the-money, as the exercise price of the stock options exceeded the market price of the Company’s common stock.
Schedule of Outstanding RSUs and PSUs summary of the Company’s outstanding RSUs and PSUs, assuming the current estimated level of performance achievement (in thousands, except years):
March 31, 2023
(in thousands, except period)
Unvested units 1,577 
Remaining cost on unvested units $ 3,503 
Remaining vesting period 3.75 years